Etodolac ext-rel Tablets Rx
Generic Name and Formulations:
Etodolac 400mg, 500mg, 600mg; ext rel tabs.
Various generic manufacturers
Indications for Etodolac ext-rel Tablets:
Osteoarthritis. Rheumatoid arthritis.
400mg–1g once daily; max 1.2g/day.
Aspirin allergy. Late pregnancy. Coronary artery bypass graft surgery.
Discontinue if signs/symptoms of liver disease develop. History of upper GI disease. Asthma. Renal or hepatic impairment. Advanced kidney disease: not recommended. Heart failure. Hypertension. Edema. Bleeding disorders. Monitor blood, hepatic, renal, and ocular function in chronic use. Dehydrated. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Antacids reduce serum levels. Avoid salicylates, phenylbutazone. Monitor anticoagulants, cyclosporine, lithium, digoxin, methotrexate. Renal toxicity may be potentiated with diuretics. May antagonize ACE inhibitors.
NSAID (pyranocarboxylic acid deriv.).
Dyspepsia, GI upset, edema, asthenia/malaise, dizziness, dysuria, urinary frequency, depression, nervousness, renal or hepatic toxicity, rash (discontinue if occurs), pruritus, chills/fever, GI bleed, peptic ulcer. See literature re: risk of cardiovascular events.
Formerly known under the brand names Lodine (caps, tabs); Lodine XL (ext-rel tabs).
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|